MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00404-020-05696-y

Медицинская библиотека · Archives of gynecology and obstetrics · 2020

Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.

De Diego María Victoria, Gómez-Pardo Olga, Groar Janette Kirk, López-Escobar Alejandro, Martín-Estal Irene, Castilla-Cortázar Inma, Rodríguez-Zambrano Miguel Ángel

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: To investigate the metabolic impact of currently used therapies in polycystic ovary syndrome (PCOS).

METHODS

This is an observational, retrospective and transversal protocol. A small cohort of 133 patients, aged 14-48 years, diagnosed with PCOS was divided into four experimental groups: 1) untreated PCOS patients (n = 51); 2) PCOS patients treated with one of the following therapies (n = 82): a) combined oral contraceptives (COC, n = 35); b) metformin (n = 11); and c) inositols (n = 36).

RESULTS

Although only < 10% of patients included in this cohort can be strictly encompassed in the development of metabolic syndrome, approximately 20% had insulin resistance. In PCOS patients, COC treatment modified the hormonal profile and worsened lipid parameters (increasing cholesterol and triglyceride levels) and insulin resistance, whereas inositol therapies improved significantly insulin resistance and glycosylated hemoglobin, reducing cholesterol and triglyceride levels. In these women, obesity was associated with greater alterations in lipid and glycemic metabolism and with higher blood pressure levels. PCOS patients with phenotype A presented vaster alterations in lipid metabolism and higher values of glycosylated hemoglobin as well as blood pressure compared to other PCOS phenotypes.

CONCLUSIONS

Results in this paper suggest that inositol therapies (alone or combined with COC) are the most useful therapies with the best benefits against PCOS symptoms. Thus, integrative treatment may become a more efficient long-term choice to control PCOS symptoms. Furthermore, obesity can be considered as an adverse symptom and calorie restriction a key element of combined treatment in PCOS, not only for fertility management but also in long-term metabolic sequelae.

Для цитирования: De Diego María Victoria, Gómez-Pardo Olga, Groar Janette Kirk, López-Escobar Alejandro, Martín-Estal Irene, Castilla-Cortázar Inma, Rodríguez-Zambrano Miguel Ángel. Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.. Archives of gynecology and obstetrics. 2020. DOI: 10.1007/s00404-020-05696-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.